VALEANT PHARMACEUTICALS INTL INC CDA 5.5 percent 01Nov2025 is a Note issued by the corporate entity on the 2nd of October 2017. Bausch is trading at 89.50 as of the 18th of January 2025, a 8.44 percent decrease since the beginning of the trading day. The bond's open price was 97.75. Bausch has about a 39 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Ratings for Bausch Health Companies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of November 2024 and ending today, the 18th of January 2025. Click here to learn more.
Our tools can tell you how much better you can do entering a position in Bausch without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Insider Screener Now
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bausch financial ratios help investors to determine whether Bausch Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bausch with respect to the benefits of owning Bausch security.